News & Updates

Glucose-lowering medications protect against glaucoma, AMD
Glucose-lowering medications protect against glaucoma, AMD
29 Jul 2022

While diabetes is a risk factor for cataract, glucose-lowering medications appear to have a protective effect on the risks of open-angle glaucoma (OAG) and age-related macular degeneration (AMD), as shown in a study.

Glucose-lowering medications protect against glaucoma, AMD
29 Jul 2022
Paternal IBD medication use before conception carries no excess risk of childhood infections
Paternal IBD medication use before conception carries no excess risk of childhood infections
28 Jul 2022
Short-course quinolones, pivmecillinam on par with standard regimens in uncomplicated cystitis
Short-course quinolones, pivmecillinam on par with standard regimens in uncomplicated cystitis
27 Jul 2022 byJairia Dela Cruz

For women with acute uncomplicated cystitis, treatment regimens that include third- and fourth-generation quinolones and pivmecillinam can be administered in shorter courses, which perform similarly to the currently recommended regimens in terms of achieving symptomatic cure, according to the results of a meta-analysis presented at the 37th Annual European Association of Urology (EAU) Congress.

Short-course quinolones, pivmecillinam on par with standard regimens in uncomplicated cystitis
27 Jul 2022
Maternal vaccination reduces COVID-19 hospitalization risk in offspring
Maternal vaccination reduces COVID-19 hospitalization risk in offspring
27 Jul 2022 byElaine Soliven

Full vaccination (two doses) with an mRNA COVID-19 vaccine during pregnancy was associated with a reduced risk of COVID-19-related hospitalization among infants younger than 6 months of age, according to a recent study.

Maternal vaccination reduces COVID-19 hospitalization risk in offspring
27 Jul 2022
Myopericarditis risk after COVID-19 vaccine not greater than after other vaccines
Myopericarditis risk after COVID-19 vaccine not greater than after other vaccines
26 Jul 2022 byRoshini Claire Anthony

The risk of myopericarditis after COVID-19 vaccination is not greater than that following other non–COVID-19 vaccinations, according to a systematic review and meta-analysis conducted by researchers in Singapore.

Myopericarditis risk after COVID-19 vaccine not greater than after other vaccines
26 Jul 2022
UltraVIOLET: Oteseconazole turns in satisfactory results for recurrent yeast infection
UltraVIOLET: Oteseconazole turns in satisfactory results for recurrent yeast infection
26 Jul 2022 byJairia Dela Cruz

In the treatment and prevention of recurrent yeast infection or vulvovaginal candidiasis, oteseconazole performs similarly to standard-of-care fluconazole but better as compared with placebo, as shown in the results of the phase III ultraviolet study.

UltraVIOLET: Oteseconazole turns in satisfactory results for recurrent yeast infection
26 Jul 2022